BridgeBio Pharma, Inc. (BBIO) — Analyst estimates
Consensus analyst estimates for BridgeBio Pharma, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 295.24M | -0.3 | 3 |
| 2027 | 461.7M | 0.36 | 2 |
| 2028 | 653.13M | 1.16 | 5 |
| 2029 | 927.78M | 2.28 | 2 |
| 2030 | 4.47B | 10.09 | 12 |
Consensus analyst estimates by fiscal year.